Multi-center randomized phase II trial of pemetrexed plus oxaliplatin or pemetrexed alone as the second line treatment for stage IV non-squamous non-small cell lung cancer

被引：0
|
作者：
Gong, Y. [1 ,2 ]
Ren, L. [1 ,2 ]
Huang, M. [1 ,2 ]
Li, L. [1 ,2 ]
Peng, F. [1 ,2 ]
Hou, M. [1 ,2 ]
Li, W. [3 ]
Jia, Y. [4 ]
Yang, H. [5 ]
Lu, Y. [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Thorac Oncol, Chengdu 610064, Sichuan, Peoples R China
[2] State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China
[3] Canc Hosp Yunnan Prov, Dept Med Oncol, Kunming, Peoples R China
[4] Second Renmin Hosp Yibin City, Dept Med Oncol, Yibin, Peoples R China
[5] Kunming Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Kunming, Peoples R China
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3499
引用
收藏
页码：S828 / S828
页数：1
相关论文
共 50 条
  • [1] A phase II study of oxaliplatin and pemetrexed plus bevacizumab in advanced non-squamous non-small cell lung cancer
    Waples, J. M.
    Auerbach, M.
    Boccia, R.
    Wiggans, R. G.
    Steis, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    [J]. ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
  • [3] A randomised phase II study of pemetrexed versus pemetrexed plus erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer
    Dittrich, Christian
    Papai-Szekely, Zsolt
    Vinolas, Nuria
    Sederholm, Christer
    Hartmann, Joerg T.
    Behringer, Dirk
    Kazeem, Gbenga
    Desaiah, Durisala
    Leschinger, Monika I.
    von Pawel, Joachim
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (09) : 1571 - 1580
  • [4] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [5] Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan
    Asami, Kazuhiro
    Kawahara, Masaaki
    Hirashima, Tomonori
    Suzuki, Hidekazu
    Okishio, Kyoichi
    Omachi, Naoki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Hirooka, Aya
    Nakao, Keiko
    Tsuji, Taisuke
    Atagi, Shinji
    [J]. THORACIC CANCER, 2014, 5 (04) : 289 - 296
  • [6] Luminespib plus pemetrexed in patients with non-squamous non-small cell lung cancer
    Noor, Zorawar S.
    Goldman, Jonathan W.
    Lawler, William E.
    Telivala, Bijoy
    Braiteh, Fadi
    DiCarlo, Brian A.
    Kennedy, Kathleen
    Adams, Brad
    Wang, Xiaoyan
    Jones, Benjamin
    Slamon, Dennis J.
    Garon, Edward B.
    [J]. LUNG CANCER, 2019, 135 : 104 - 109
  • [7] A RANDOMIZED PHASE 2 STUDY OF ERLOTINIB PLUS PEMETREXED VS ERLOTINIB OR PEMETREXED ALONE AS SECOND-LINE TREATMENT FOR NEVER-SMOKER PATIENTS WITH NON-SQUAMOUS ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Lee, D. H.
    Lee, J. S.
    Kim, S. W.
    Rodrigues Pereira, J.
    Han, B.
    Song, X. Q.
    Wang, J.
    Kim, H-K.
    Sahoo, T. P.
    Digumarti, R.
    Wang, X.
    Altug, S.
    Orlando, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 400 - 400
  • [8] RANDOMIZED PHASE II STUDY OF PEMETREXED PLUS CARBOPLATIN FOLLOWED BY PEMETREXED VERSUS PACLITAXEL PLUS CARBOPLATIN FOLLOWED BY PEMETREXED IN ADVANCED NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (LOGIK 0904)
    Shiraishi, Yoshimasa
    Inoue, Koji
    Takeshita, Masafumi
    Harada, Taishi
    Tashiro, Naoki
    Seto, Takashi
    Imanaga, Tomotoshi
    Fujimoto, Noriko
    Nakagaki, Noriaki
    Kawasaki, Masayuki
    Kishimoto, Junji
    Takayama, Koichi
    Ichinose, Yukito
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S403 - S404
  • [9] Treatment of stage IIIb/IV non-small cell lung cancer with Pemetrexed plus Oxaliplatin after failure of Erlotinib as second-line treatment
    Sheng-Bin Shi
    Rong-Hang Hu
    Jie-Lin Qi
    Xiao-Yong Tang
    Jing Tian
    Rui Li
    Chun-Xiao Chang
    [J]. Medical Oncology, 2013, 30
  • [10] Treatment of stage IIIb/IV non-small cell lung cancer with Pemetrexed plus Oxaliplatin after failure of Erlotinib as second-line treatment
    Shi, Sheng-Bin
    Hu, Rong-Hang
    Qi, Jie-Lin
    Tang, Xiao-Yong
    Tian, Jing
    Li, Rui
    Chang, Chun-Xiao
    [J]. MEDICAL ONCOLOGY, 2013, 30 (02)
12345